about
Pyridoxamine: the many virtues of a maillard reaction inhibitor.Protocol-based metabolic evaluation in high-risk patients with renal stones in North India.Mechanistic Insights into the Antilithiatic Proteins from Terminalia arjuna: A Proteomic Approach in UrolithiasisProtective impact of resveratrol in experimental rat model of hyperoxaluria.COM crystals activate the p38 mitogen-activated protein kinase signal transduction pathway in renal epithelial cells.Idiopathic calcium oxalate urolithiasis and endogenous oxalate production.Oxalate selectively activates p38 mitogen-activated protein kinase and c-Jun N-terminal kinase signal transduction pathways in renal epithelial cells.Vitamin E therapy prevents hyperoxaluria-induced calcium oxalate crystal deposition in the kidney by improving renal tissue antioxidant status.
P2860
Q34436025-8A321CBF-A98D-4E17-8DD5-981413AE0A93Q35856098-2D2CFE5B-C776-4FCB-B743-8B1D98936E1CQ36138544-4027222E-082B-44AA-A771-A444C13FFD8DQ38759102-4D4926A8-58C6-4103-B317-58993BD9A04BQ40717860-76DFB5E4-4250-43FB-892B-362F6C926D50Q41133065-F93237F9-EB3E-4F74-AB65-44BFFA7A3D4DQ43874023-22C33FD1-CD4D-4F82-90FD-D19C7B277AC6Q46552906-B29E9C36-2C0C-42B4-9661-F5EECC751B3F
P2860
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Clinical review 32: Calcium oxalate nephrolithiasis.
@ast
Clinical review 32: Calcium oxalate nephrolithiasis.
@en
type
label
Clinical review 32: Calcium oxalate nephrolithiasis.
@ast
Clinical review 32: Calcium oxalate nephrolithiasis.
@en
prefLabel
Clinical review 32: Calcium oxalate nephrolithiasis.
@ast
Clinical review 32: Calcium oxalate nephrolithiasis.
@en
P356
P1476
Clinical review 32: Calcium oxalate nephrolithiasis.
@en
P304
P356
10.1210/JC.74.4.703
P407
P577
1992-04-01T00:00:00Z